Serum lipoproteins in day and shift workers: a prospective study.
Open Access
- 1 February 1990
- journal article
- research article
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 47 (2) , 132-134
- https://doi.org/10.1136/oem.47.2.132
Abstract
This study was designed to assess changes in diet and serum lipoproteins in shift workers. Twelve shift workers and 13 day workers were examined before employment and after six months at work. Total cholesterol and serum triglycerides did not change significantly. In both groups a decrease in systolic blood pressure was observed. The ratio between apoB and apoA-1 lipoproteins increased by 18% in shift workers compared with 5% in day workers. The change in the ratio between apoB and apoA-1 lipoproteins showed a significant inverse correlation with the change in intake of dietary fibres.Keywords
This publication has 20 references indexed in Scilit:
- Prevalence of risk factors for coronary artery disease among day and shift workers.Scandinavian Journal of Work, Environment & Health, 1988
- INCREASED RISK OF ISCHAEMIC HEART DISEASE IN SHIFT WORKERSThe Lancet, 1986
- Shift work and cardiovascular disease.Scandinavian Journal of Work, Environment & Health, 1984
- Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery diseaseAtherosclerosis, 1984
- Health risks related to shift workInternationales Archiv für Arbeitsmedizin, 1983
- Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery diseaseAtherosclerosis, 1983
- Discriminative value of lipids and apoproteins in coronary heart diseaseAtherosclerosis, 1982
- Myocardial infarction risk and psychosocial work environment: An analysis of the male Swedish working forceSocial Science & Medicine, 1982
- Kinetic immunoturbidimetry: the estimation of albuminClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?The Lancet, 1979